As a significant development, Gubra has announced the signing of a new research and license agreement with Boehringer Ingelheim to discover novel peptides for the treatment of obesity
Warning signs requiring medical attention include: Severe dizziness, fainting, or falls Persistent nausea, vomiting, or abdominal pain Signs of allergic reaction (rash, itching, swelling, difficulty breathing) call 999 for severe allergic reactions (anaphylaxis) Unusual fatigue or weakness Changes in urination patterns or flank pain (potential kidney issues) Palpitations or irregular heartbeat Severe chest pain or fainting call 999 immediately It is important to inform all healthcare professionalsincluding your GP, pharmacist, and any specialistsabout all supplements you take
Introduce the hydrosol to the peptide mix, stirring with care
Dosages in studies showing benefits have ranged from 200 to 300 mg per day in children and adolescents, and 340 to 450 mg per day in adults
This warning was grounded on a wide number of studies reviewed in (Micallef et al., 2020b) including a recent report of the French Pharmacovigilance Network conducted in 2019 ( more topical than ever (Micallef et al., 2020b)
It is a moot point for me as I do not methylate B12 well without self testing for that reality